Report cover image

Asia Pacific Stem Cell Therapy Market, By Type (Autologous, Allogeneic); By Cell Source (Adipose Tissue-derived, MSC, Bone Marrow, Placenta/Umbilical Cord); By Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological); By End User (Ho

Publisher BlueWeave Consulting
Published Jan 30, 2024
Length 328 Pages
SKU # BLWC18529291

Description

Asia Pacific Stem Cell Therapy Market Size Expands at Significant CAGR of 10.48% to Surpass USD 5 Billion by 2030

Asia Pacific Stem Cell Therapy Market is experiencing significant momentum due to the adoption of swift technological advancements and an increasing demand for stem cell therapy across the region.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Asia Pacific Stem Cell Therapy Market size at USD 2.76 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Asia Pacific Stem Cell Therapy Market size to grow at a CAGR of 10.48% reaching a value of USD 5.02 billion by 2030. The Asia Pacific Stem Cell Therapy Market is primarily driven by increasing investments in research and development of effective therapies to treat rising prevalence of chronic diseases and growing awareness about the therapeutic potential of stem cells. Advancements in healthcare infrastructure, a surge in government initiatives, and the expanding elderly population contribute to market growth. Additionally, collaborations between research institutions and pharmaceutical companies, coupled with favorable regulatory frameworks, propel the adoption of stem cell therapies. The region's robust biotechnology sector and the pursuit of innovative treatment options further stimulate market expansion, fostering a conducive environment for advancements in stem cell therapy across diverse medical applications.

Opportunity – Development of personalized stem cell therapies

In the dynamic landscape of the Asia Pacific Stem Cell Therapy Market, the advent of personalized stem cell therapies emerges as a formidable growth driver. The innovative approach of stem cell therapies tailors treatments to individual patients, unlocking unprecedented potential for targeted and effective medical solutions. With a focus on precision medicine, the development of stem cell therapies not only enhances patient outcomes but also accelerates the market expansion, marking a paradigm shift in regenerative medicine across the Asia Pacific region.

Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market

On March 11, 2020, the World Health Organization (WHO) declared COVID-19 a pandemic. In response to this global health crisis, researchers have been actively pursuing innovative cures and treatments. Recent years have demonstrated the efficacy of stem cell therapy in treating respiratory conditions, particularly COVID-19. The official international registry for clinical trials has recorded at least 10 projects focused on utilizing mesenchymal stem cells to treat patients with coronavirus pneumonia. The surge in research and clinical trials has led to an increased demand for stem cell therapy, consequently boosting the growth of Stem Cell Therapy Market.

Asia Pacific Stem Cell Therapy Market

Segmental Coverage

Asia Pacific Stem Cell Therapy Market – By Type

Based on type, Asia Pacific Stem Cell Therapy Market is divided into Autologous and Allogeneic segments. Autologous stem cell therapy involves using a patient's cells for treatment, offering personalized and efficient solutions. The segment's prominence reflects the region's growing focus on personalized medicine and the potential for enhanced therapeutic outcomes through patient-specific treatments. Allogeneic stem cell therapy, which uses cells from a donor, also contributes to the market, catering to specific medical needs. However, the dominance of the autologous segment underscores the demand for tailored healthcare solutions in the Asia Pacific region.

Asia Pacific Stem Cell Therapy Market – By Cell Source

By cell source, Asia Pacific Stem Cell Therapy Market is divided into Adipose Tissue-derived, MSC, Bone Marrow, and Placenta/Umbilical Cord segments. The mesenchymal stem cells (MSC) segment is the largest cell source in the Asia Pacific Stem Cell Therapy Market. MSCs have gained prominence due to their versatility in differentiation and therapeutic applications, contributing significantly to the region's stem cell therapy market. With widespread research and clinical applications, MSCs stand out as the leading segment, reflecting their pivotal role in advancing regenerative medicine across diverse medical fields in the Asia Pacific region.

Competitive Landscape

Asia Pacific Stem Cell Therapy Market is fiercely competitive. Major companies in the market include Bristol Myers Squibb Company, Gilead Sciences Inc, JCR Pharmaceuticals Co Ltd, Kolon TissueGene Inc, Medipost Co Ltd, Smith & Nephew Plc, Vericel Corporation, Takeda Pharmaceutical Company Limited, and Mesoblast Ltd. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Asia Pacific Stem Cell Therapy Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Asia Pacific Stem Cell Therapy Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Asia Pacific Stem Cell Therapy Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

328 Pages
1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Asia Pacific Stem Cell Therapy Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Growing awareness of stem cell therapy
3.2.2. Restraints
3.2.2.1. High cost of stem cell therapy
3.2.2.2. Lack of regulation and standardization:
3.2.3. Opportunities
3.2.3.1. Development of personalized stem cell therapies:
3.2.3.2. Expansion into new therapeutic areas:
3.2.4. Challenges
3.2.4.1. Limited clinical data:
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Asia Pacific Stem Cell Therapy Market Overview
4.1. Market Size & Forecast by Value & Volume, 2019–2030
4.1.1. By Value (USD Billion)
4.2. Market Share & Forecast
4.2.1. By Type
4.2.1.1. Autologous
4.2.1.2. Allogeneic
4.2.2. By Cell Source
4.2.2.1. Adipose Tissue-Derived
4.2.2.2. MSC
4.2.2.3. Bone Marrow
4.2.2.4. Placenta/Umbilical Cord
4.2.3. By Application
4.2.3.1. Musculoskeletal
4.2.3.2. Wounds
4.2.3.3. Surgeries
4.2.3.4. Cardiovascular
4.2.3.5. Neurological
4.2.4. By End User
4.2.4.1. Hospitals & Clinics
4.2.4.2. Academic & Research Institutes
4.2.5. By Country
4.2.5.1. China
4.2.5.2. India
4.2.5.3. Japan
4.2.5.4. South Korea
4.2.5.5. Australia & New Zealand
4.2.5.6. Indonesia
4.2.5.7. Malaysia
4.2.5.8. Singapore
4.2.5.9. Vietnam
4.2.5.10. Rest of APAC
5. China Stem Cell Therapy Market Overview
5.1. Market Size & Forecast by Value & Volume, 2019–2030
5.1.1. By Value (USD Billion)
5.2. Market Share & Forecast
5.2.1. By Type
5.2.2. By Cell Source
5.2.3. By Application
5.2.4. By End User
6. India Stem Cell Therapy Market Overview
6.1. Market Size & Forecast by Value & Volume, 2019–2030
6.1.1. By Value (USD Billion)
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Cell Source
6.2.3. By Application
6.2.4. By End User
7. Japan Stem Cell Therapy Market Overview
7.1. Market Size & Forecast by Value & Volume, 2019–2030
7.1.1. By Value (USD Billion)
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Cell Source
7.2.3. By Application
7.2.4. By End User
8. South Korea Stem Cell Therapy Market Overview
8.1. Market Size & Forecast by Value & Volume, 2019–2030
8.1.1. By Value (USD Billion)
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Cell Source
8.2.3. By Application
8.2.4. By End User
9. Australia & New Zealand Stem Cell Therapy Market Overview
9.1. Market Size & Forecast by Value & Volume, 2019–2030
9.1.1. By Value (USD Billion)
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Cell Source
9.2.3. By Application
9.2.4. By End User
10. Indonesia Stem Cell Therapy Market Overview
10.1. Market Size & Forecast by Value & Volume, 2019–2030
10.1.1. By Value (USD Billion)
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Cell Source
10.2.3. By Application
10.2.4. By End User
11. Malaysia Stem Cell Therapy Market Overview
11.1. Market Size & Forecast by Value & Volume, 2019–2030
11.1.1. By Value (USD Billion)
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Cell Source
11.2.3. By Application
11.2.4. By End User
12. Singapore Stem Cell Therapy Market Overview
12.1. Market Size & Forecast by Value & Volume, 2019–2030
12.1.1. By Value (USD Billion)
12.2. Market Share & Forecast
12.2.1. By Type
12.2.2. By Cell Source
12.2.3. By Application
12.2.4. By End User
13. Vietnam Stem Cell Therapy Market Overview
13.1. Market Size & Forecast by Value & Volume, 2019–2030
13.1.1. By Value (USD Billion)
13.2. Market Share & Forecast
13.2.1. By Type
13.2.2. By Cell Source
13.2.3. By Application
13.2.4. By End User
14. Rest of APAC Stem Cell Therapy Market Overview
14.1. Market Size & Forecast by Value & Volume, 2019–2030
14.1.1. By Value (USD Billion)
14.2. Market Share & Forecast
14.2.1. By Type
14.2.2. By Cell Source
14.2.3. By Application
14.2.4. By End User
15. Competitive Landscape
15.1. List of Key Players and Their Offerings
15.2. Asia Pacific Stem Cell Therapy Company Market Share Analysis, 2023
15.3. Competitive Benchmarking, By Operating Parameters
15.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)
16. Impact of COVID-19 on Asia Pacific Stem Cell Therapy Market
17. Impact of Escalating Geopolitical Tensions on Asia Pacific Stem Cell Therapy Market
18. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
18.1. Bristol Myers Squibb Company
18.2. Gilead Sciences Inc
18.3. JCR Pharmaceuticals Co Ltd,
18.4. Kolon TissueGene Inc
18.5. MEDIPOST Co Ltd,
18.6. Smith & Nephew Plc,
18.7. Vericel Corporation
18.8. Takeda Pharmaceutical Company Limited
18.9. Mesoblast Ltd
18.10. Other Prominent Players
19. Key Strategic Recommendations
20. Research Methodology
20.1. Qualitative Research
20.1.1. Primary & Secondary Research
20.2. Quantitative Research
20.3. Market Breakdown & Data Triangulation
20.3.1. Secondary Research
20.3.2. Primary Research
20.4. Breakdown of Primary Research Respondents, By Region
20.5. Assumption & Limitation
*Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
Figure 1 Asia Pacific Stem Cell Therapy Market Segmentation
Figure 2 Asia Pacific Stem Cell Therapy Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 5 Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 6 Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 7 Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 8 Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 9 Asia Pacific Stem Cell Therapy Market Share, By Country, By Value, 2019–2030
Figure 10 China Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 11 China Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 12 China Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 13 China Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 14 China Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 15 India Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 16 India Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 17 India Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 18 India Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 19 India Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 20 Japan Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 21 Japan Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 22 Japan Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 23 Japan Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 24 Japan Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 25 South Korea Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 26 South Korea Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 27 South Korea Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 28 South Korea Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 29 South Korea Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 30 Australia & New Zealand Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 31 Australia & New Zealand Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 32 Australia & New Zealand Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 33 Australia & New Zealand Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 34 Australia & New Zealand Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 35 Indonesia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 36 Indonesia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 37 Indonesia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 38 Indonesia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 39 Indonesia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 40 Malaysia Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 41 Malaysia Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 42 Malaysia Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 43 Malaysia Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 44 Malaysia Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 45 Singapore Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 46 Singapore Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 47 Singapore Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 48 Singapore Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 49 Singapore Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 50 Vietnam Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 51 Vietnam Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 52 Vietnam Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 53 Vietnam Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 54 Vietnam Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
Figure 55 Rest of Asia Pacific Stem Cell Therapy Market Size, By Value (USD Billion), 2019–2030
Figure 56 Rest of Asia Pacific Stem Cell Therapy Market Share, By Type, By Value, 2019–2030
Figure 57 Rest of Asia Pacific Stem Cell Therapy Market Share, By Cell Source, By Value, 2019–2030
Figure 58 Rest of Asia Pacific Stem Cell Therapy Market Share, By Application, By Value, 2019–2030
Figure 59 Rest of Asia Pacific Stem Cell Therapy Market Share, By End User, By Value, 2019–2030
List of Tables
Table 1 Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 2 Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 3 Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 4 Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 5 Asia Pacific Stem Cell Therapy Market Size, By Country, By Value, 2019–2030
Table 6 China Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 7 China Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 8 China Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 9 China Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 10 India Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 11 India Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 12 India Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 13 India Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 14 Japan Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 15 Japan Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 16 Japan Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 17 Japan Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 18 South Korea Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 19 South Korea Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 20 South Korea Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 21 South Korea Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 22 Australia & New Zealand Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 23 Australia & New Zealand Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 24 Australia & New Zealand Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 25 Australia & New Zealand Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 26 Indonesia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 27 Indonesia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 28 Indonesia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 29 Indonesia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 30 Malaysia Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 31 Malaysia Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 32 Malaysia Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 33 Malaysia Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 34 Singapore Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 35 Singapore Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 36 Singapore Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 37 Singapore Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 38 Vietnam Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 39 Vietnam Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 40 Vietnam Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 41 Vietnam Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 42 Rest of Asia Pacific Stem Cell Therapy Market Size, By Type, By Value, 2019–2030
Table 43 Rest of Asia Pacific Stem Cell Therapy Market Size, By Cell Source, By Value, 2019–2030
Table 44 Rest of Asia Pacific Stem Cell Therapy Market Size, By Application, By Value, 2019–2030
Table 45 Rest of Asia Pacific Stem Cell Therapy Market Size, By End User, By Value, 2019–2030
Table 46 Bristol Myers Squibb Company: Company Overview
Table 47 Bristol Myers Squibb Company Financial Overview
Table 48 Gilead Sciences Inc Company Overview
Table 49 Gilead Sciences Inc Financial Overview
Table 50 JCR Pharmaceuticals Co Ltd, Company Overview
Table 51 JCR Pharmaceuticals Co Ltd, Financial Overview
Table 52 Kolon TissueGene Inc Company Overview
Table 53 Kolon TissueGene Inc Financial Overview
Table 54 MEDIPOST Co Ltd, Company Overview
Table 55 MEDIPOST Co Ltd, Financial Overview
Table 56 Smith & Nephew Plc, Company Overview
Table 57 Smith & Nephew Plc, Financial Overview
Table 58 Vericel Corporation Company Overview
Table 59 Vericel Corporation Financial Overview
Table 60 Takeda Pharmaceutical Company Limited Company Overview
Table 61 Takeda Pharmaceutical Company Limited Financial Overview
Table 62 Mesoblast Ltd Company Overview
Table 63 Mesoblast Ltd Financial Overview

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us